NO169841C - Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive (arylfenyl- eller thienylmethyl)-2,2'-bi-1h-imidazoler - Google Patents

Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive (arylfenyl- eller thienylmethyl)-2,2'-bi-1h-imidazoler

Info

Publication number
NO169841C
NO169841C NO883322A NO883322A NO169841C NO 169841 C NO169841 C NO 169841C NO 883322 A NO883322 A NO 883322A NO 883322 A NO883322 A NO 883322A NO 169841 C NO169841 C NO 169841C
Authority
NO
Norway
Prior art keywords
arylphenyl
thienylmethyl
imidazoles
preparation
new
Prior art date
Application number
NO883322A
Other languages
English (en)
Norwegian (no)
Other versions
NO883322L (no
NO169841B (no
NO883322D0 (no
Inventor
Donald P Matthews
James R Mccarthy
Jeffrey P Whitten
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO883322D0 publication Critical patent/NO883322D0/no
Publication of NO883322L publication Critical patent/NO883322L/no
Publication of NO169841B publication Critical patent/NO169841B/no
Publication of NO169841C publication Critical patent/NO169841C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO883322A 1987-07-28 1988-07-27 Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive (arylfenyl- eller thienylmethyl)-2,2'-bi-1h-imidazoler NO169841C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/078,352 US4839375A (en) 1987-07-28 1987-07-28 (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents

Publications (4)

Publication Number Publication Date
NO883322D0 NO883322D0 (no) 1988-07-27
NO883322L NO883322L (no) 1989-01-30
NO169841B NO169841B (no) 1992-05-04
NO169841C true NO169841C (no) 1992-08-12

Family

ID=22143494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883322A NO169841C (no) 1987-07-28 1988-07-27 Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive (arylfenyl- eller thienylmethyl)-2,2'-bi-1h-imidazoler

Country Status (19)

Country Link
US (1) US4839375A (pt)
EP (1) EP0301456B1 (pt)
JP (1) JP2750578B2 (pt)
KR (1) KR970011301B1 (pt)
CN (1) CN1016173B (pt)
AT (1) ATE101151T1 (pt)
AU (1) AU605609B2 (pt)
CA (1) CA1338786C (pt)
DE (1) DE3887585T2 (pt)
DK (1) DK420588A (pt)
ES (1) ES2063008T3 (pt)
FI (1) FI883499A (pt)
HU (1) HU202861B (pt)
IL (1) IL87217A (pt)
NO (1) NO169841C (pt)
NZ (1) NZ225561A (pt)
PH (1) PH26551A (pt)
PT (1) PT88121B (pt)
ZA (1) ZA885360B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0949314B1 (en) * 1998-03-20 2006-06-14 China Petrochemical Corporation Hydrodesulfurisation of hydrocarbon oils

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283661C (en) * 1984-06-20 1991-04-30 Franz Jansen Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates
ZA868809B (en) * 1985-11-25 1987-07-29 Merrell Dow Pharma Novel 2,2'-bi-1h-imidazoles
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR970011301B1 (ko) 1997-07-09
ES2063008T3 (es) 1995-01-01
ATE101151T1 (de) 1994-02-15
IL87217A (en) 1992-07-15
EP0301456A2 (en) 1989-02-01
CN1034718A (zh) 1989-08-16
AU1976588A (en) 1989-02-02
FI883499A0 (fi) 1988-07-25
HU202861B (en) 1991-04-29
JPS6440465A (en) 1989-02-10
AU605609B2 (en) 1991-01-17
DE3887585T2 (de) 1994-05-26
PH26551A (en) 1992-08-19
NZ225561A (en) 1990-12-21
NO883322L (no) 1989-01-30
PT88121B (pt) 1995-03-01
CN1016173B (zh) 1992-04-08
EP0301456B1 (en) 1994-02-02
DK420588D0 (da) 1988-07-27
EP0301456A3 (en) 1990-12-05
US4839375A (en) 1989-06-13
JP2750578B2 (ja) 1998-05-13
NO169841B (no) 1992-05-04
ZA885360B (en) 1989-03-29
DE3887585D1 (de) 1994-03-17
IL87217A0 (en) 1988-12-30
PT88121A (pt) 1989-07-31
KR890002112A (ko) 1989-04-08
NO883322D0 (no) 1988-07-27
CA1338786C (en) 1996-12-10
DK420588A (da) 1989-01-29
HUT53900A (en) 1990-12-28
FI883499A (fi) 1989-01-29

Similar Documents

Publication Publication Date Title
KR910009684A (ko) 방향족 아민 화합물, 이의 제조방법 및 이들의 존재하는 약제학적 조성물
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
FI905280A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista bentsopyridopiperidiini-, piperidylideeni- ja -piperatsiiniyhdistettä
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
FR2639349B1 (fr) Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
RU94023250A (ru) 2,3-дигидро-1,4-бензодиоксин-5-ил-пиперазиновые производные, обладающие 5-нт1а-антагонистической активностью, способы их получения, фармкомпозиция на их основе, получение ее и способ лечения расстройств нервной системы
NO871861L (no) Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer.
KR890001957A (ko) N-아미노부틸-n-페닐아릴아미드 유도체, 그의 제법 및 치료에의 응용
HUP9802447A2 (hu) Piperazinszármazékok, eljárás előállításukra és 5-HT1A antagonistaként történő alkalmazásuk
FI791639A (fi) Nya imidazolderivat foerfaranden foer framstaellning av dem och farmaceutiska preparat innehaollande dessa
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
NO902099L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylsulfonamider.
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
NO176097C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener
NO169841C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive (arylfenyl- eller thienylmethyl)-2,2'-bi-1h-imidazoler
JPS6016933B2 (ja) 2,6−ジメチル−3,5−ジメトキシカルボニル−4−(0−ジフルオロメトキシフエニル)−1,4−ジヒドロピリジン
ES500810A0 (es) Procedimiento de preparacion de aminoalcoxipirazoles
FR2623501B1 (fr) Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
NO914567L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridylderivater
NO894698D0 (no) Kondenserte heterocykliske derivater av 1,2,3,4-tetrahydroakridiner samt fremgangsmaate for fremstilling derav.
ITMI920082A1 (it) Derivati solforati di acidi biliari
GB1116775A (en) ªß-hydroxy-acrylic acid derivatives and process for their manufacture
DE69002983D1 (de) Thioformamid-Derivate.